Teladoc Health, Inc. (TDOC) recently showcased data from two studies at the American Diabetes Association's 84th Scientific Sessions. These studies highlight Teladoc's predictive modeling capabilities in aiding members with type 2 diabetes to manage their blood sugar levels through its diabetes management program. Following the news, the stock gained 6.7% yesterday. Members identified as at-risk for uncontrolled diabetes by artificial intelligence (AI) and prompted with health notifications or nudges on the ...